These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1997858)

  • 1. Doxorubicin-induced cardiac toxicity.
    Doroshow JH
    N Engl J Med; 1991 Mar; 324(12):843-5. PubMed ID: 1997858
    [No Abstract]   [Full Text] [Related]  

  • 2. Adriamycin cardiac toxicity: a different hypothesis.
    Byfield JE
    Cancer Treat Rep; 1977; 61(3):497-8. PubMed ID: 872149
    [No Abstract]   [Full Text] [Related]  

  • 3. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats.
    Giri SN; Al-Bayati MA; Du X; Schelegle E; Mohr FC; Margolin SB
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):141-50. PubMed ID: 14564477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy.
    Benjamin RS; Mason JW; Billingham ME
    Cancer Treat Rep; 1978 Jun; 62(6):935-9. PubMed ID: 667871
    [No Abstract]   [Full Text] [Related]  

  • 5. Doxorubicin-induced chronic cardiotoxicity and its protection by liposomal administration.
    Rahman A; More N; Schein PS
    Cancer Res; 1982 May; 42(5):1817-25. PubMed ID: 7066898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adriamycin cardiotoxicity amelioration by alpha-tocopherol.
    Krivit W
    Am J Pediatr Hematol Oncol; 1979; 1(2):151-3. PubMed ID: 543510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does catalase play a role in adriamycin induced cardiotoxicity?
    D'Alessandro N; Dusonchet L; Crosta L; Crescimanno M; Rausa L
    Pharmacol Res Commun; 1980 May; 12(5):441-6. PubMed ID: 7443752
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity.
    Herman EH; Lipshultz SE; Rifai N; Zhang J; Papoian T; Yu ZX; Takeda K; Ferrans VJ
    Cancer Res; 1998 Jan; 58(2):195-7. PubMed ID: 9443390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum carnitine levels during the doxorubicin therapy. Its role in cardiotoxicity.
    Yaris N; Ceviz N; Coskun T; Akytüz C; Büyükpamukçu M
    J Exp Clin Cancer Res; 2002 Jun; 21(2):165-70. PubMed ID: 12148572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible role of adriamycinol in the cardiotoxicity induced by adriamycin in the rat].
    Danesi R; Del Tacca M; Ducci M; Bernardini C; Romanini A
    G Ital Chemioter; 1985; 32(1):31-3. PubMed ID: 3830790
    [No Abstract]   [Full Text] [Related]  

  • 11. Doxorubicin-induced cardiotoxicity.
    Silber JH; Barber G
    N Engl J Med; 1995 Nov; 333(20):1359-60. PubMed ID: 7566043
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adriamycin cardiotoxicity].
    Recalcatri F; Villa A; Belli C
    G Ital Cardiol; 1982; 12(8):612-6. PubMed ID: 7169160
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiotoxicity in children treated with anthracyclines: the role of M-mode echocardiography.
    Galli MA; Conter V; Zanetto F; Jankovic M; Ferrari L; Baio G; Masera G
    Haematologica; 1987; 72(4):347-50. PubMed ID: 3117636
    [No Abstract]   [Full Text] [Related]  

  • 14. High incidence of cardiomyopathy in children treated with adriamycin and DTIC in combination chemotherapy.
    Smith PJ; Ekert H; Waters Kd; Matthews RN
    Cancer Treat Rep; 1977 Dec; 61(9):1736-8. PubMed ID: 597823
    [No Abstract]   [Full Text] [Related]  

  • 15. Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma.
    Hershman DL; McBride RB; Eisenberger A; Tsai WY; Grann VR; Jacobson JS
    J Clin Oncol; 2008 Jul; 26(19):3159-65. PubMed ID: 18591554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.
    Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics.
    Tokarska-Schlattner M; Zaugg M; Zuppinger C; Wallimann T; Schlattner U
    J Mol Cell Cardiol; 2006 Sep; 41(3):389-405. PubMed ID: 16879835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
    Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
    J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiotoxicity of anthracyclines in children. Contribution of anthracyclines in pediatric oncology].
    Biron P; Philip T; Bouffet E; Favrot MC; Pinkerton R; Brunat-Mentigny M
    Pathol Biol (Paris); 1987 Jan; 35(1):97-101. PubMed ID: 3550619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-induced cardiotoxicity.
    Paz-Ares L; Dobbs N; Twelves C
    N Engl J Med; 1995 Nov; 333(20):1360. PubMed ID: 7566044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.